N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine

C97H119Cl5F3N19O4 — CID 161387062

IUPACN-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine
SMILESCC(=O)N(CCc1ccncc1)C1CCC(CN)(c2cccc(Cl)c2)CC1.CN(C(=O)c1cccnn1)C1CCC(CN)(c2cccc(Cl)c2)CC1.CN(C(=O)c1ccnnc1)C1CCC(CN)(c2cccc(Cl)c2)CC1.NCC1(c2cccc(Cl)c2)CCC(N2CCCCC2=O)CC1.NCC1(c2cccc(Cl)c2)CCC(Nc2ccc3nnc(C(F)(F)F)n3n2)CC1
InChIInChI=1S/C22H28ClN3O.C19H20ClF3N6.2C19H23ClN4O.C18H25ClN2O/c1-17(27)26(14-9-18-7-12-25-13-8-18)21-5-10-22(16-24,11-6-21)19-3-2-4-20(23)15-19;20-13-3-1-2-12(10-13)18(11-24)8-6-14(7-9-18)25-15-4-5-16-26-27-17(19(21,22)23)29(16)28-15;1-24(18(25)17-6-3-11-22-23-17)16-7-9-19(13-21,10-8-16)14-4-2-5-15(20)12-14;1-24(18(25)14-7-10-22-23-12-14)17-5-8-19(13-21,9-6-17)15-3-2-4-16(20)11-15;19-15-5-3-4-14(12-15)18(13-20)9-7-16(8-10-18)21-11-2-1-6-17(21)22/h2-4,7-8,12-13,15,21H,5-6,9-11,14,16,24H2,1H3;1-5,10,14H,6-9,11,24H2,(H,25,28);2-6,11-12,16H,7-10,13,21H2,1H3;2-4,7,10-12,17H,5-6,8-9,13,21H2,1H3;3-5,12,16H,1-2,6-11,13,20H2
InChIKeyVSMIOQUXSVJTCX-UHFFFAOYSA-N
MW1849.41 g/mol
LogP17.59
Rot. Bonds21

About N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine

N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine (PubChem CID 161387062) has the molecular formula C97H119Cl5F3N19O4 and a molecular weight of 1849.41 g/mol. Its IUPAC name is N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine.

Molecular Properties

Compound NameN-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine
PubChem CID161387062
Molecular FormulaC97H119Cl5F3N19O4
Molecular Weight1849.41 g/mol
Exact Mass1845.81
IUPAC NameN-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine
SMILESCC(=O)N(CCc1ccncc1)C1CCC(CN)(c2cccc(Cl)c2)CC1.CN(C(=O)c1cccnn1)C1CCC(CN)(c2cccc(Cl)c2)CC1.CN(C(=O)c1ccnnc1)C1CCC(CN)(c2cccc(Cl)c2)CC1.NCC1(c2cccc(Cl)c2)CCC(N2CCCCC2=O)CC1.NCC1(c2cccc(Cl)c2)CCC(Nc2ccc3nnc(C(F)(F)F)n3n2)CC1
InChIInChI=1S/C22H28ClN3O.C19H20ClF3N6.2C19H23ClN4O.C18H25ClN2O/c1-17(27)26(14-9-18-7-12-25-13-8-18)21-5-10-22(16-24,11-6-21)19-3-2-4-20(23)15-19;20-13-3-1-2-12(10-13)18(11-24)8-6-14(7-9-18)25-15-4-5-16-26-27-17(19(21,22)23)29(16)28-15;1-24(18(25)17-6-3-11-22-23-17)16-7-9-19(13-21,10-8-16)14-4-2-5-15(20)12-14;1-24(18(25)14-7-10-22-23-12-14)17-5-8-19(13-21,9-6-17)15-3-2-4-16(20)11-15;19-15-5-3-4-14(12-15)18(13-20)9-7-16(8-10-18)21-11-2-1-6-17(21)22/h2-4,7-8,12-13,15,21H,5-6,9-11,14,16,24H2,1H3;1-5,10,14H,6-9,11,24H2,(H,25,28);2-6,11-12,16H,7-10,13,21H2,1H3;2-4,7,10-12,17H,5-6,8-9,13,21H2,1H3;3-5,12,16H,1-2,6-11,13,20H2
InChIKeyVSMIOQUXSVJTCX-UHFFFAOYSA-N
XLogP17.59
TPSA330.90 Ų
H-Bond Donors6
H-Bond Acceptors19
Rotatable Bonds21
Heavy Atoms128
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001849.41
LogP ≤ 517.59
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1019

Analyze N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine?
The IUPAC name of N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine (CID 161387062) is N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine.
What is the SMILES notation for N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine?
The canonical SMILES for N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine is CC(=O)N(CCc1ccncc1)C1CCC(CN)(c2cccc(Cl)c2)CC1.CN(C(=O)c1cccnn1)C1CCC(CN)(c2cccc(Cl)c2)CC1.CN(C(=O)c1ccnnc1)C1CCC(CN)(c2cccc(Cl)c2)CC1.NCC1(c2cccc(Cl)c2)CCC(N2CCCCC2=O)CC1.NCC1(c2cccc(Cl)c2)CCC(Nc2ccc3nnc(C(F)(F)F)n3n2)CC1.
What is the InChIKey of N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine?
The InChIKey is VSMIOQUXSVJTCX-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H28ClN3O.C19H20ClF3N6.2C19H23ClN4O.C18H25ClN2O/c1-17(27)26(14-9-18-7-12-25-13-8-18)21-5-10-22(16-24,11-6-21)19-3-2-4-20(23)15-19;20-13-3-1-2-12(10-13)18(11-24)8-6-14(7-9-18)25-15-4-5-16-26-27-17(19(21,22)23)29(16)28-15;1-24(18(25)17-6-3-11-22-23-17)16-7-9-19(13-21,10-8-16)14-4-2-5-15(20)12-14;1-24(18(25)14-7-10-22-23-12-14)17-5-8-19(13-21,9-6-17)15-3-2-4-16(20)11-15;19-15-5-3-4-14(12-15)18(13-20)9-7-16(8-10-18)21-11-2-1-6-17(21)22/h2-4,7-8,12-13,15,21H,5-6,9-11,14,16,24H2,1H3;1-5,10,14H,6-9,11,24H2,(H,25,28);2-6,11-12,16H,7-10,13,21H2,1H3;2-4,7,10-12,17H,5-6,8-9,13,21H2,1H3;3-5,12,16H,1-2,6-11,13,20H2.
What are the key properties of N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine?
N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine has a molecular weight of 1849.41 g/mol, XLogP of 17.59, 21 rotatable bonds, 6 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-3-carboxamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-methylpyridazine-4-carboxamide;1-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]piperidin-2-one;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-N-(2-pyridin-4-ylethyl)acetamide;N-[4-(aminomethyl)-4-(3-chlorophenyl)cyclohexyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine is sourced from PubChem (CID 161387062), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).